コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 us- pituitary-adrenal (HPA) axis response to arterial hypotension.
2 of cerebral blood flow despite correction of arterial hypotension.
3 pulmonary disease (1.8 [1.2-2.7]), systolic arterial hypotension (2.9 [1.7-5.0]), tachypnoea (2.0 [1
4 rtension acting as a predisposing factor and arterial hypotension actually producing the disorders.
6 a life-threatening kidney disease featuring arterial hypotension along with electrolyte abnormalitie
9 ked human hemoglobin can ameliorate systemic arterial hypotension and improve organ perfusion in a po
10 eletal muscle injury produced early systemic arterial hypotension and vasodilation, and a decrease in
11 ympathoexcitatory responses induced by acute arterial hypotension; and (vi) activation of the intracr
12 r cardiovascular or cerebrovascular disease, arterial hypotension at admission, and black or Latino e
14 S) mRNA and protein expression, and systemic arterial hypotension in a rat model of septic shock.
15 M40401, modulates serum cytokine levels and arterial hypotension in an Escherichia coli-infected con
17 secondary analyses we found that exposure to arterial hypotension induced E-selectin and thrombin-ant
20 nsive medications for arterial hypertension, arterial hypotension (particularly nocturnal hypotension
21 are significantly correlated with nocturnal arterial hypotension, particularly in hypertensive patie
23 objective was to determine whether post-ROSC arterial hypotension predicts outcome among postcardiac
24 ion, but significantly increased the risk of arterial hypotension, pruritus, urinary retention, and m
25 ith etomidate, episodes of apnea, hypoxia or arterial hypotension requiring therapeutic intervention
26 than 24 hours after status epilepticus, and arterial hypotension requiring vasopressors were indepen